EMD Millipore, the Life Science division of Merck KGaA, has launched Provantage Solutions, a portfolio of process development, manufacturing consulting and implementation services, provided by the company’s scientists, engineers, and applications specialists. The new offering, launched at BIO 2012, can be delivered either onsite at a drug manufacturer’s facility, at EMD Millipore’s advanced bioproduction facility in Martillac, France or at one of their six access labs around the world.

“Until now, the options for process development and manufacturing were limited to internal resources or conventional outsourcing,” said Christophe Couturier, vice president of Services and Solutions, EMD Millipore. “While each option has pros and cons, Provantage Solutions integrates the best of each and helps accelerate the journey of a molecule to commercial phase.”

The initial offerings are in two segments, Biodevelopment and Clinical Supply Solutions, and Bioprocess Consulting Solutions. The former includes a biologics manufacturing solution that incorporates “the latest technologies in upstream, downstream and single-use systems
Includes process development and validation services,” GMP production for preclinical to Phase II, and technology transfer and scale-up services for Phase III and commercial production.

The latter segment includes a range of projects with defined milestones, deliverables and business outcomes, from upstream through to commercial tech transfer, as well as expertise, products, services and technology to help solve clients’ business problems or challenges.